Cittadine Andrew

Reporting owner on Forms 3, 4 and 5, CIK 1863624.

Cittadine Andrew reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.

Issuers

Issuer	Roles in the latest filing	Filings	Last filed
Monopar Therapeutics CIK 1645469	officer (Chief Operating Officer)	1	2026-10-02

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

Security	Date	Code	Shares	Price	Owned after	Filing
Monopar Therapeutics Common Stock	2026-09-30	M exercised	+4,384		59,998	Form 4
Monopar Therapeutics Common Stock	2026-09-30	F withheld for tax	-1,944	$79.67	58,054	Form 4
Monopar Therapeutics Restricted Stock Unit, derivative	2026-09-30	M exercised	-4,384	$0	35,115	Form 4

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

Filing	Subject	Filed	Accepted	Ingested
Form 4 0001437749-26-031927	Monopar Therapeutics	2026-10-02	2026-10-02 22:15:10 UTC	2026-10-06 10:21:18 UTC